PT1152762E - Utilizacao de desoxipeganina no tratamento da demencia de alzheimer - Google Patents
Utilizacao de desoxipeganina no tratamento da demencia de alzheimerInfo
- Publication number
- PT1152762E PT1152762E PT00907513T PT00907513T PT1152762E PT 1152762 E PT1152762 E PT 1152762E PT 00907513 T PT00907513 T PT 00907513T PT 00907513 T PT00907513 T PT 00907513T PT 1152762 E PT1152762 E PT 1152762E
- Authority
- PT
- Portugal
- Prior art keywords
- dementia
- alzheimer
- treatment
- deoxygeganin
- desoxypeganine
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- WUFQLZTXIWKION-UHFFFAOYSA-N Deoxypeganine Chemical compound C1C2=CC=CC=C2N=C2N1CCC2 WUFQLZTXIWKION-UHFFFAOYSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19906975A DE19906975B4 (de) | 1999-02-19 | 1999-02-19 | Arzneiform zur Behandlung von Alzheimer'scher Demenz |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1152762E true PT1152762E (pt) | 2005-08-31 |
Family
ID=7898022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT00907513T PT1152762E (pt) | 1999-02-19 | 2000-02-08 | Utilizacao de desoxipeganina no tratamento da demencia de alzheimer |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6436937B1 (enExample) |
| EP (1) | EP1152762B8 (enExample) |
| JP (1) | JP2002537256A (enExample) |
| KR (1) | KR20010102219A (enExample) |
| AT (1) | ATE294584T1 (enExample) |
| AU (1) | AU2907700A (enExample) |
| DE (2) | DE19906975B4 (enExample) |
| ES (1) | ES2242605T3 (enExample) |
| PT (1) | PT1152762E (enExample) |
| WO (1) | WO2000048599A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19906978B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Pharmazeutische Zusammensetzung enthaltend Desoxypeganin zur Behandlung der Drogenabhängigkeit |
| DE19906979B4 (de) * | 1999-02-19 | 2004-07-08 | Lts Lohmann Therapie-Systeme Ag | Verwendung von Desoxypeganin zur Behandlung der Nikotinabhängigkeit |
| WO2002017919A2 (en) * | 2000-08-28 | 2002-03-07 | Sention, Inc. | Use of threo-methylphenidate compounds to enhance memory |
| AU2001286861A1 (en) * | 2000-08-28 | 2002-03-13 | Sention, Inc. | Use of methylphenidate compounds to enhance memory |
| DE10119863A1 (de) * | 2001-04-24 | 2002-11-07 | Hf Arzneimittelforsch Gmbh | Verwendung von Desoxypeganin zur Behandlung von psychiatrischen oder zerebralen Krankheitserscheinungen |
| DE10163667B4 (de) * | 2001-12-21 | 2006-10-26 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung der klinischen Depression |
| JP4498922B2 (ja) * | 2002-07-09 | 2010-07-07 | アクテリオン ファーマシューティカルズ リミテッド | ７，８，９，１０−テトラヒドロ−６Ｈ−アゼピノ、６，７，８，９−テトラヒドロ−ピリドおよび２，３−ジヒドロ−２Ｈ−ピロロ［２，１−ｂ］−キナゾリノン誘導体 |
| DE10304141B4 (de) | 2003-02-03 | 2006-03-09 | Hf Arzneimittelforschung Gmbh | Verfahren zur Herstellung von Chinazolin-Alkaloiden |
| DE10354893B4 (de) * | 2003-11-24 | 2011-03-10 | Hf Arzneimittelforschung Gmbh | Verwendung von Desoxypeganin zur Behandlung schizophrener Psychosen |
| CN101433565B (zh) * | 2008-11-26 | 2013-06-05 | 上海中医药大学 | 骆驼蓬属种子总生物碱提取物和它们的制备 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU605614A1 (ru) * | 1971-10-20 | 1978-05-05 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узбекской Сср | Антихолинэстеразное средство |
| SU878295A1 (ru) * | 1979-07-04 | 1981-11-07 | Ордена Трудового Красного Знамени Институт Химии Растительных Веществ Ан Узсср | Способ получени дезоксипеганина гидрохлорида |
| US5750542A (en) | 1993-09-28 | 1998-05-12 | Pfizer | Benzisoxazole and benzisothizole derivatives as cholinesterase inhibitors |
| DE19509663A1 (de) * | 1995-03-17 | 1996-09-19 | Lohmann Therapie Syst Lts | Verfahren zur Isolierung von Galanthamin |
| SE9504618D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Ab | New Compounds |
-
1999
- 1999-02-19 DE DE19906975A patent/DE19906975B4/de not_active Expired - Fee Related
-
2000
- 2000-02-08 KR KR1020017010459A patent/KR20010102219A/ko not_active Ceased
- 2000-02-08 US US09/913,638 patent/US6436937B1/en not_active Expired - Fee Related
- 2000-02-08 AT AT00907513T patent/ATE294584T1/de not_active IP Right Cessation
- 2000-02-08 AU AU29077/00A patent/AU2907700A/en not_active Abandoned
- 2000-02-08 DE DE50010234T patent/DE50010234D1/de not_active Expired - Fee Related
- 2000-02-08 JP JP2000599391A patent/JP2002537256A/ja active Pending
- 2000-02-08 ES ES00907513T patent/ES2242605T3/es not_active Expired - Lifetime
- 2000-02-08 PT PT00907513T patent/PT1152762E/pt unknown
- 2000-02-08 WO PCT/EP2000/000972 patent/WO2000048599A1/de not_active Ceased
- 2000-02-08 EP EP00907513A patent/EP1152762B8/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1152762B1 (de) | 2005-05-04 |
| US6436937B1 (en) | 2002-08-20 |
| WO2000048599A1 (de) | 2000-08-24 |
| ES2242605T3 (es) | 2005-11-16 |
| AU2907700A (en) | 2000-09-04 |
| DE50010234D1 (de) | 2005-06-09 |
| EP1152762A1 (de) | 2001-11-14 |
| EP1152762B8 (de) | 2005-06-29 |
| ATE294584T1 (de) | 2005-05-15 |
| KR20010102219A (ko) | 2001-11-15 |
| DE19906975A1 (de) | 2000-08-24 |
| JP2002537256A (ja) | 2002-11-05 |
| DE19906975B4 (de) | 2004-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI962557A7 (fi) | PLA2-inhibiittoreiden käyttö Alzheimerin taudin hoidossa | |
| NO20022531D0 (no) | Vaksine for forebyggelse og behandling av Alzheimer og amyloidrelaterte sykdommer | |
| GB0005251D0 (en) | Therapeutic compounds | |
| FI955315L (fi) | HIV:n proteaasin inhibiittoreita, jotka ovat käyttökelpoisia AIDS'n hoitoon | |
| ATE385794T1 (de) | Benzothiazolderivate zur behandlung von alzheimer und parkinson | |
| AU2003284968A8 (en) | Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease | |
| PT1594833E (pt) | Derivados do ácido 1-fenilalcanocarboxílico para o tratamento de doenças neurodegenerativas | |
| IS4972A (is) | Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm | |
| AU5716898A (en) | Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease | |
| CA2387873A1 (en) | Nordihydroguaiaretic derivatives for use in treatment of tumors | |
| AU3173301A (en) | Methods and compositions for treatment of alzheimer's disease by enhancing plasmin or plasmin-like activity | |
| AU2002335794A1 (en) | Allylamides useful in the treatment of alzheimer's disease | |
| ZA977310B (en) | Transdermal propentofylline compositions for the treatment of Alzheimer's disease. | |
| AU2002212471A1 (en) | Peptides for use in the treatment of alzheimer's disease | |
| EP1152762B8 (de) | Verwendung von desoxypeganin zur behandlung von alzheimerischer demenz | |
| DE69420229D1 (de) | Pharmazeutische Zusammensetzung zur Behandlung von AIDS | |
| PT1007040E (pt) | Utilizacao de fanquinona no tratamento da doenca de alzheimer | |
| FI971127L (fi) | 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen | |
| PT932400E (pt) | Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica | |
| MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
| CA2260863A1 (en) | Treatment of psychotic disorders | |
| EE200000290A (et) | Toimeainete, nimelt tetrahüdropüridiinide ja atsetüülkoliinesteraasi inhibiitorite, kombinatsioon Alzheimeri tõve tüüpi seniildementsuse raviks | |
| ATE236633T1 (de) | Topische verwendung von loperamid zur behandlung mikrobieller infektionen | |
| DK0836853T3 (da) | Anvendelse af bradykinin-antagonister til fremstilling af lægemidler til behandling og forebyggelse af Alzheimers sygdom | |
| UA36252A (uk) | Спосіб визначення індивідуальності хворого для вибору адекватної гомеопатичної терапії |